$25.30

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI06606_5_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Acetyl-DL-valine
Brand Name
Chem Impex
Product Number
06606
CAS
3067-19-4
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
227752
IUPAC Name
2-acetamido-3-methylbutanoic acid
InChI Key
IHYJTAOFMMMOPX-UHFFFAOYSA-N
SMILES
CC(C)C(C(=O)O)NC(=O)C

Application

Acetyl-DL-valine is widely utilized in research focused on:

Pharmaceutical Development: This compound serves as a building block in the synthesis of various pharmaceuticals, particularly in the development of peptide-based drugs that target specific biological pathways.

Protein Engineering: It is used in the modification of amino acids to create novel proteins with enhanced stability and activity, which is crucial for biotechnological applications.

Nutrition Supplements: Acetyl-DL-valine is incorporated into dietary supplements aimed at improving muscle recovery and performance, appealing to athletes and fitness enthusiasts.

Research on Metabolic Disorders: This chemical aids in studies related to metabolic pathways, providing insights into conditions such as diabetes and obesity, thereby supporting the development of targeted therapies.

Cosmetic Formulations: It is also found in cosmetic products for its potential benefits in skin health, helping to enhance the texture and hydration of skincare formulations.

References Data Source From Pubchem

Comparative urinary metabolomics reveals unique and shared pathways in COVID-19 and liver diseases

Publication Name: Metabolomics : Official journal of the Metabolomic Society
Publication Date: 2026-02-27
DOI: 10.1007/s11306-026-02394-9

Sexual dimorphism in the serum metabolome following acute exhaustive exercise

Publication Name: Biology of Sex Differences
Publication Date: 2025-11-06
DOI: 10.1186/s13293-025-00780-x

Circulating metabolites and bladder cancer: a Mendelian randomization and multi-omics study

Publication Name: Discover Oncology
Publication Date: 2025-10-14
DOI: 10.1007/s12672-025-03709-3

High-throughput LDI MS technology decodes the distinct metabolic landscape of prostate cancer in a large-scale cohort

Publication Name: Biomarker Research
Publication Date: 2025-07-09
DOI: 10.1186/s40364-025-00804-z